SCHEMBL7614600

SCHEMBL7614600

C=CCN1C(=O)C(OC)(OC)c2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ GAA P10253 4/20 0.51
▸ ALDH1A1 P00352 10/20 0.51
▸ POLB P06746 4/20 0.51
▸ KDM4E B2RXH2 1/20 0.50
▸ HCRTR1 O43613 1/20 0.49
▸ HCRTR2 O43614 1/20 0.49
▸ TSHR P16473 5/20 0.49
▸ KMT2A Q03164 5/20 0.48
▸ MAPT P10636 4/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ ALPL P05186 2/20 0.48
▸ ALPI P09923 2/20 0.48
▸ ALPG P10696 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ MAPK1 P28482 3/20 0.47
▸ HPGD P15428 1/20 0.47
▸ CDYL2 Q8N8U2 1/20 0.46
▸ CDYL Q9Y232 1/20 0.46
▸ CDY1; CDY1B Q9Y6F8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13234144 0.78 L3MBTL1 (0.50) L3MBTL1GAAALDH1A1POLBKDM4E
SCHEMBL7611042 0.78 ALDH1A1 (0.56) ALDH1A1HSD17B10NPSR1
SCHEMBL28393168 0.77 L3MBTL1 (0.58) L3MBTL1GAAALDH1A1POLBKDM4E
SCHEMBL10565837 0.77 L3MBTL1 (0.58) L3MBTL1GAAALDH1A1POLBKDM4E
SCHEMBL7609556 0.77 AKR1B1 (0.37) L3MBTL1GAAALDH1A1LMNA
SCHEMBL12659924 0.75 L3MBTL1 (0.53) L3MBTL1GAAALDH1A1POLBKDM4E
SCHEMBL12659470 0.73 L3MBTL1 (0.61) L3MBTL1GAAALDH1A1POLBKDM4E
SCHEMBL7614781 0.73 PKM (0.37) GAAALDH1A1POLBKMT2AMEN1
SCHEMBL4261414 0.70 ALDH1A1 (0.53) L3MBTL1GAAALDH1A1POLBKDM4E
SCHEMBL1750577 0.70 ALDH1A1 (0.69) L3MBTL1GAAALDH1A1POLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0685463-B1 INDOLIN-2-ONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2002-05-22 — — EP disclosed
US-6207836-B1 Indolin-2-one derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2001-03-27 — — US disclosed
US-6127544-A 1-SUBSTITUTED-3-UREIDO-INDOLIN-2-ONES WHICH EXHIBIT SELECTIVE ANTAGONISM AGAINST GASTRIN RECEPTORS WITHOUT CAUSING SIDE EFFECTS ATTRIBUTED TO CCK-A RECEPTOR ANTAGONISM; SUCH AS FOR TREATMENT OF PEPTIC ULCERS, GASTRITIS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-10-03 — — US disclosed
US-6114536-A ANTAGONISM AGAINST GASTRIN RECEPTORS WITHOUT CAUSING SIDE EFFECTS ATTRIBUTED TO CCK-A RECEPTOR ANTAGONISM AND ARE USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES OF DIGESTIVE ORGANS, SUCH AS PEPTIC ULCER, GASTRITIS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-09-05 — — US disclosed
US-6031111-A Indolin-2-one derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-02-29 — — US disclosed
US-5952511-A EXHIBITS SELECTIVE ANTAGONISM AGAINST GASTRIN RECEPTOR WITHOUT CAUSING SIDE EFFECTS ATTRIBUTED TO GASTRIN RECEPTOR ANTAGONISM AND USEFUL FOR TREATING PEPTIC ULCER, GASTRITIS, REFLUX ESOPHAGITIS AND ZOLLINGER-ELLISON SYNDROME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1999-09-14 — — US disclosed
EP-0685463-A1 INDOLIN-2-ONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1995-12-06 — — EP disclosed
Send feedback